| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 乙酰基-11-酮基-beta-乳香酸; 3-O-Acetyl-11-keto-beta-boswellic acid | CFN90531 | 67416-61-9 | C32H48O5 = 512.72 | 20mg | QQ客服：215959384 |
| 葫芦素S； 雪胆素甲; Cucurbitacin S | CFN90535 | 60137-06-6 | C30H42O6 = 498.65 | 5mg | QQ客服：1457312923 |
| 匙羹藤酸I; Gymnemic acid I | CFN90538 | 122168-40-5 | C43H66O14 = 806.97 | 5mg | QQ客服：1457312923 |
| 楤木皂苷A，竹节参皂苷IV; Chikusetsusaponin IV | CFN90542 | 7518-22-1 | C47H74O18 = 927.08 | 20mg | QQ客服：3257982914 |
| Glycoside L-F2; Glycoside L-F2 | CFN00446 | 243857-99-0 | C41H66O13 = 766.96 | 5mg | QQ客服：1413575084 |
| 龙牙楤木皂甙VII; Tarasaponin VII | CFN90543 | 144118-18-3 | C52H84O21 = 1045.22 | 5mg | QQ客服：3257982914 |
| 3-氧代坡模酸; 3-Oxopomolic acid | CFN92574 | 13849-90-6 | C30H46O4 = 470.7 | 5mg | QQ客服：3257982914 |
| Ethyl ganoderate J; Ethyl ganoderate J | CFN92576 | 1189555-95-0 | C32H46O7 = 542.7 | 5mg | QQ客服：215959384 |
| 人参皂苷Rk3; Ginsenoside Rk3 | CFN92593 | 364779-15-7 | C36H60O8 = 620.9 | 10mg | QQ客服：3257982914 |
| 人参皂苷Rh4; Ginsenoside Rh4 | CFN92594 | 174721-08-5 | C36H60O8 = 620.9 | 10mg | QQ客服：2056216494 |
| 刺五加皂苷E; Ciwujianoside E | CFN92596 | 114912-36-6 | C40H62O11 = 718.9 | 5mg | QQ客服：2056216494 |
| 齐墩果-12-烯-3b,6b-二醇; 12-Oleanene-3,6-diol | CFN94009 | 41498-79-7 | C30H50O2 = 442.72 | 5 mg | QQ客服：1413575084 |
| 曼陀罗萜醇酮; Daturaolone | CFN94010 | 41498-80-0 | C30H48O2 = 440.71 | 5 mg | QQ客服：1413575084 |
| Rosamultic acid; Rosamultic acid | CFN92608 | 214285-76-4 | C30H46O5 = 486.7 | 5mg | QQ客服：3257982914 |
| 1-beta-羟基蔷薇酸; 1beta-Hydroxyeuscaphic acid | CFN92609 | 120211-98-5 | C30H48O6 = 504.7 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)